Cargando…
Chemotherapeutic Interventions Against Tuberculosis
Tuberculosis is the second leading cause of infectious deaths globally. Many effective conventional antimycobacterial drugs have been available, however, emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) has overshadowed the effectiveness of...
Autores principales: | Shakya, Neeraj, Garg, Gaurav, Agrawal, Babita, Kumar, Rakesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763665/ https://www.ncbi.nlm.nih.gov/pubmed/24281707 http://dx.doi.org/10.3390/ph5070690 |
Ejemplares similares
-
New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells
por: Gupta, Nancy, et al.
Publicado: (2018) -
Tuberculosis: The Chemotherapeutic Approaches
por: Brownlee, George
Publicado: (1949) -
Harnessing Innate Immunity to Treat Mycobacterium tuberculosis Infections: Heat-Killed Caulobacter crescentus as a Novel Biotherapeutic
por: Gupta, Nancy, et al.
Publicado: (2023) -
Broader use of hepatitis B virus vaccine: Efficacy in those who lost hepatitis B surface antigen during follow-up
por: Kumar, Rakesh, et al.
Publicado: (2011) -
The Chemotherapeutic Potentials of Compounds Isolated from the Plant, Marine, Fungus, and Microorganism: Their Mechanism of Action and Prospects
por: Shakya, Ashok K., et al.
Publicado: (2022)